Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Acquired by JPMorgan Chase & Co.

JPMorgan Chase & Co. increased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 17.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,126,607 shares of the company’s stock after purchasing an additional 454,044 shares during the period. JPMorgan Chase & Co. owned approximately 3.37% of Acadia Healthcare worth $198,258,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of ACHC. Principal Financial Group Inc. boosted its position in Acadia Healthcare by 2.1% during the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock worth $41,653,000 after purchasing an additional 13,368 shares in the last quarter. Oddo BHF Asset Management Sas purchased a new stake in Acadia Healthcare in the 3rd quarter valued at about $1,613,000. Franklin Resources Inc. increased its position in Acadia Healthcare by 273.1% during the third quarter. Franklin Resources Inc. now owns 105,228 shares of the company’s stock worth $6,673,000 after purchasing an additional 77,027 shares during the last quarter. Tidal Investments LLC raised its position in shares of Acadia Healthcare by 7.9% in the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock worth $296,000 after buying an additional 340 shares during the period. Finally, Teachers Retirement System of The State of Kentucky raised its holdings in shares of Acadia Healthcare by 8.5% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 56,594 shares of the company’s stock worth $3,589,000 after purchasing an additional 4,426 shares during the period.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. KeyCorp began coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Cantor Fitzgerald reiterated a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Barclays decreased their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. Royal Bank of Canada lowered their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research note on Monday, November 18th. Finally, StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, December 19th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $75.44.

Acadia Healthcare Stock Performance

ACHC opened at $38.58 on Tuesday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The company has a market capitalization of $3.58 billion, a price-to-earnings ratio of 12.65, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The business has a 50 day moving average price of $41.93 and a two-hundred day moving average price of $59.62. Acadia Healthcare Company, Inc. has a 1-year low of $36.50 and a 1-year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the business earned $0.91 earnings per share. Research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.